BERLIN (Reuters) -German medical technology firm Brainlab set the price range for its initial public offering at 80 to 100 ...

German medical technology firm Brainlab said on Monday it had set the price range for its initial public offering (IPO) at 80 ...

Brainlab, the German medical technology company, set the price range for its forthcoming IPO at €80 to €100 a share on Monday ...

Medical technology software firm Brainlab AG and its shareholders are seeking up to €400 million ($460 million) in its Frankfurt initial public offering, as several European companies look to list ...

German medical technology firm Brainlab is planning an initial public offering on the Frankfurt Stock Exchange in the coming ...

All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

Brainlab, the German medical technology company, is planning to list in Frankfurt in the coming weeks. Berenberg and Deutsche ...

Brainlab AG considers Frankfurt IPO, potential valuation at EUR 2 billion ...

Market capitalization after withdrawal of founder Stefan Vilsmeier: Brainlab appears to be aiming for an IPO in Frankfurt in the second half of the year. The Munich-based company for medical ...

Der Medizinsoftware-Spezialist Brainlab erwägt informierten Kreisen ... welche Banken für die Begleitung eines IPO infrage kommen. Eine Börsennotierung könnte den Entwickler von Software ...

Investing.com -- Medical (TASE: PMCN) technology firm Brainlab AG is reportedly exploring options for an initial public offering (IPO) in Frankfurt, according to Bloomberg sources familiar with the ...

Brainlab AG considers Frankfurt IPO, potential valuation at EUR 2 billion View all comments (0) 0 Investing.com -- Medical (TASE: PMCN) technology firm Brainlab AG is reportedly exploring options ...